GlassScriptPhysician profile
Yan Mei Luo
NPI 1255713095
$922.00
in general payments reported to CMS, 2019-2025
18 companies · $159 in 2025
The $159 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.29 · 2020: $123 · 2021: $109 · 2022: $111 · 2023: $82.61 · 2024: $272 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $145.58 | 2019-2025 | |
| Abbvie INC. | $145.50 | 2021-2025 | |
| Synaptic Medical Corporation | $120.29 | 2024 | |
| Novo Nordisk INC | $118.18 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $68.05 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Lilly USA, LLC | $44.06 | 2025 | Zepbound, Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.97 | 2020-2021 | |
| Viiv Healthcare Company | $38.00 | 2024-2025 | Apretude |
| Glaxosmithkline, LLC. | $31.58 | 2022-2023 | Arexvy |
| Bausch Health US, LLC | $30.87 | 2019-2020 | |
| Amgen INC. | $29.62 | 2024-2025 | Repatha, Otezla, Otezla |
| Dynavax Technologies Corporation | $27.68 | 2019-2022 | |
| Althera Pharmaceuticals LLC | $15.55 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.00 | 2020 | |
| Seqirus USA INC | $14.71 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $13.77 | 2022 | |
| Arbor Pharmaceuticals, INC. | $11.48 | 2020 | |
| Astellas Pharma US INC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Mei Luo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.